Modulation of the humoral response to repeat and non-repeat sequences of the circumsporozoite protein of Plasmodium vivax using novel adjuvant and delivery systems

REFERENCES

• Aguado, M. T. & Lambert, P. H. (1992). Controlled release vaccines—biodegradable polylactide/glycolide (PL/PG) microspheres as antigen vehicles. Immunobiology, 184, 113–125
   PubMed Web of Science ®Google Scholar
• Ahluwalia, A., Gokulan, K., Nath, I. & Rao, D. N. (1997). Modification of delivery system enhances MHC nonrestricted immunogenicity of V3 loop. Microbiology and Immunology, 41, 779–784.
   PubMed Web of Science ®Google Scholar
• Arevalo-Herrera, M., Roggero, M. A., Gonzalez, J. M., Vergara, J., Corradin, G., Lopez, J. A. & Herrera, S. (1998). Mapping and comparison of the B-cell epitopes recognized on the Plasmodium vivax circumsporozoite protein by immune Colombians and immunized Aotus monkeys. Annals of Tropical Medicine Parasitology, 92, 539–551.
   PubMed Web of Science ®Google Scholar
• Arnot, D. E., Barnwell, J. W., Tam, J. P., Nussenweig, V., Nussenweig, R. S. & Eneas, V. (1985). Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope. Science, 230, 815–818.
   PubMed Web of Science ®Google Scholar
• Avrameas, S. & Ternynck, T. C. (1969). The cross linking of proteins with glutaraldehyde and its use for the preparation of immunosorbents. Immunochemistry, 6, 53–66.
   PubMedGoogle Scholar
• Bachmann, M. F., Hengartner, H. & Zinkernagel, R. M. (1995). T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction? European Journal of Immunology, 25, 3445–3451.
   PubMed Web of Science ®Google Scholar
• Bharadwaj, A., Sharma, P., Joshi, S. K., Singh, B. & Chauhan, V. S. (1998). Induction of protective immune responses by immunization with linear multiepitope peptides based on conserved sequences from Plasmodium falciparum antigens. Infection and Immunity, 66, 3232–3241.
   PubMed Web of Science ®Google Scholar
• Bhattacharya, M., Puri, A., Sahai, R., Haq, W., Tripathi, L. M. & Srivastava, V. M. L. (1998). Immunosuppressant activity in human β-casein fragment analogs. Bioorganic and Medicinal Chemistry Letters, 8, 327–332.
   PubMed Web of Science ®Google Scholar
• Bilsborough, J., Baumgart, K., Bathurst, I, Barr, P. & Good, M. F. (1997). Fine epitope specificity of antibodies to region II of the Plasmodium vivax circumsporozoite protein correlates with ability to bind recombinant protein and sporozoites. Acta Tropica, 65, 59–80.
   PubMed Web of Science ®Google Scholar
• Blanco-Prieto, M. J., Delie, F., Fattal, A., Tartar, F., Puissieux, F., Gulik, A. & Couvreur, P. (1994). Characterization of V3BRU peptide loaded small PLGA microparticles prepared by a (W1/O)W2 emulsion solvent evaporation method. International Journal of Pharmacology, 111, 137–145.
   Google Scholar
• Bomford, R., Stapleton, M., Winsor, S., McKnight, A. & Andronova, T. (1992). The control of the antibody isotype response to recombinant human immunodeficiency virus gpl20 antigen by adjuvants. AIDS Research and Human Retroviruses, 8, 1765–1771.
   PubMed Web of Science ®Google Scholar
• Bradford, M. (1976). A rapid and sensitive method for quantitation of microorganism quantities of protein utilizing the principle of protein-dye binding. Annals of Biochemistry, 72, 248–254.
   Web of Science ®Google Scholar
• Charoenvit, Y., Collins, W. E., Jones, T. R., Millet, P., Yuan, L., Campbell, G. H., Beaudoin, R. L., Broderson, J. R. & Hoffman, S. L. (1991). Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science, 251, 668–671.
   PubMed Web of Science ®Google Scholar
• Coombes, A. G. A., Lavelle, E. C., Jenkins, P. G. & Davis, S. S. (1996). Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to protein antigens. Vaccine, 14, 1429–1438.
   PubMed Web of Science ®Google Scholar
• Devi, G. R., Gokulan, K. & Rao, D. N. (1995). Polytuftsin enhances the immunogenicity of peptide variants of circumsporozoite protein of Plasmodium vivax. Journal of Parasitic Diseases, 19, 117–122.
   Google Scholar
• Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R. & Gilley, R. M. (1991). Biodegradable and biocompatible poly (DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infection and Immunity, 59, 2978–2986.
   PubMed Web of Science ®Google Scholar
• Engers, H. D. & Godal, T. (1998). Malaria vaccine development: current status. Parasitology Today, 14, 56–64.
   PubMedGoogle Scholar
• Falanga, P. B., D'Imperio-lima, M. D., Coutinho, A. & Pereira da Silva, L. (1987). Isotypic pattern of the polyclonal B cell response during primary infection by P. chabaudi and in immune-protected mice. European Journal of Immunology, 17, 599–603.
   PubMed Web of Science ®Google Scholar
• Ferreira, M. U., Kimura, E. A., Katzin, A. M., Santos-Neto, L. L., Ferrari, J. O., Villalobos, J. M. & de Carvalho, M. E. (1998). The IgG-subclass distribution of naturally acquired antibodies to Plasmodium falciparum, in relation to malaria exposure and severity. Annals of Tropical Medicine and Parasitology, 92, 245–256.
   PubMed Web of Science ®Google Scholar
• Fiat, A. M., Migliore-Samour, D., Jolles, P., Drouet, L., Soller, C. B. D. & Caen, J. (1993). Biologically active peptides from milk proteins with emphasis on two examples concerning anti- thrombodial and immunomodulatory activities. Journal of Dairy Sciences, 74, 301–310.
   Google Scholar
• Franke, E. D., Lucas, C. M. & San Roman, E. (1991). Antibody response of humans to the circumsporozoite protein of Plasmodium vivax. Infection and Immunity, 59, 2836–2838.
   PubMed Web of Science ®Google Scholar
• Franke, E. D., Lucas, C. M., Chauca, G., Wirtz, R. A. & Hirostroza, S. (1992). Antibody response to circumsporozoite protein of Plasmodium vivax in naturally infected humans. American Journal of Tropical Medicine and Hygiene, 46, 320–326.
   PubMed Web of Science ®Google Scholar
• Frevert, B., Sinnis, P., Cerami, C., Shreffler, W., Takacs, B. & Nussenweig, V. (1993). Malaria circumsporozoite protein binds to heparan sulphate proteoglycans associated with the surface membrane hepatocytes. Journal of Experimental Medicine, 177, 1287–1298.
   PubMed Web of Science ®Google Scholar
• Friguet, B., Chaffotte, A. F., Djavadi-Ohaniance, L. & Goldberg, M. E. (1985). Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. Journal of Immunological Methods, 77, 305–319.
   PubMed Web of Science ®Google Scholar
• Gordon, D. M. (1993). Use of novel adjuvant and delivery systems to improve the humoral and cellular immune response to malaria vaccine candidate antigens. Vaccine, 11, 591–593.
   PubMed Web of Science ®Google Scholar
• Herrington, D. A., Nardin, E. H., Losonsky, G., Bathurst, I. C., Barr, P. J., Hollingdale, M. R., Edelman, R. & Levine, M. M. (1991). Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax. American Journal of Tropical Medicine and Hygiene, 45, 695–701.
   PubMed Web of Science ®Google Scholar
• Kain, K. C., Keystone, J., Franke, E. D. & Lanar, D. E. (1991). Global distribution of a variant of the circumsporozoite gene of Plasmodium vivax. Journal of Infectious Diseases, 164, 208–210.
   PubMed Web of Science ®Google Scholar
• Manzar, K. J. & Rao, D. N. (1991). Detection of human antibodies against Plasmodium falciparum and Plasmodium vivax sporozoites using synthetic peptides. Medical Science Research, 18, 721–723.
   Google Scholar
• Men, Y., Merkle, H. P, Gander, B. & Corradin, G. (1996). Induction of sustained and elevated immune response to weakly immunogenic synthetic malaria peptides by incorporation in biodegradable polymer microspheres. Vaccine, 14, 1442–1450.
   PubMed Web of Science ®Google Scholar
• Merrifield, R. B. (1963). Solid phase peptide synthesis. Journal of the American Chemical Society, 85, 2149–2154.
   Web of Science ®Google Scholar
• Millet, P., Chizzolini, C., Wirtz, R. A., Bathurst, I., Broderson, J. R., Campbell, G. H. & Collins, W. E. (1992). Inhibitory activity against sporozoites induced by antibodies directed against nonrepetitive regions of the circumsporozoite protein of Plasmodium vivax. European Journal of Immunology, 22, 519–524.
   PubMed Web of Science ®Google Scholar
• Nardin, E. H., Barr, P. J., Heimer, E. & Etlinger, H. M. (1988). Genetic restriction of the murine humoral response to a recombinant Plasmodium vivax circumsporozoite protein. European Journal of Immunology, 18, 1119–1122
   PubMed Web of Science ®Google Scholar
• Nussenzweig, V. & Nussenzweig, R. S. (1985). Circumsporozoite proteins of malaria parasites. Cell, 42, 401–403.
   PubMed Web of Science ®Google Scholar
• Pessi, A., Michel, M., Bianchi, E., Mendis, A., Tougne, C., Verdini, A. S., Lambert, P. H., Carter, R., Mendis, K. & del Giudice, G. (1990). Use of synthetic peptides in the study of the antibody response to Plasmodium vivax sporozoites. American Journal of Tropical Medicine and Hygiene, 42, 17–23.
   PubMed Web of Science ®Google Scholar
• Qari, S. H., Goldman, I. F., Povoa, M. M., Oliveira, S., Alpers, M. P. & Lal, A. A. (1991). Wide distribution of the variant form of the human malaria parasite Plasmodium vivax. Journal of Biological Chemistry, 266, 16 297–16 300.
   Web of Science ®Google Scholar
• Robson, K. J. H., Hall, J. R. S., Jennings, M. W., Harris, T. J. R., Marsh, K., Newbold, C. I., Tate, V. E. & Weatherall, D. J. (1988). A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature, 35, 79–82.
   Google Scholar
• Romero, P., Heimer, E. P., Herrera, S., Felix, A., Nussenzweig, R. S. & Zavala, F. (1987). Antigenic analysis of the repeat domain of the circumsporozoite protein of Plasmodium vivax. Journal of Immunology, 139, 1679–1682.
   PubMed Web of Science ®Google Scholar
• Rosenberg, R., Wirtz, R. A., Lanar, D. E., Sattabongkot, J., Hall, T., Waters, A. P. & Porasit- Tisuk, C. (1989). Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. Science, 245, 973–976.
   PubMed Web of Science ®Google Scholar
• Sahai, R., Puri, A., Saxena, R. P., Saran, R., Haq, W., Kundu, B. & Mathur, K. B. (1996). Synthesis and immunostimulant activity of novel analogs of human casein fragment (54–59). Immunopharmacology and Immunotoxicology, 18, 511–528.
   PubMed Web of Science ®Google Scholar
• Shahi, S., Kumar, P., Kamboj, K. K. & Rao, D. N. (1997). Immune response against the non-repeat region (293–310) of the circumsporozoite protein of Plasmodium vivax. Southeast Asian Journal of Tropical Medicine and Public Health, 28, 748–756.
   PubMedGoogle Scholar
• Singh, M., Li, X. M., Wang, H., McGee, J. P., Zamb, T., Koff, W., Wang, C. Y. & O'Hagan, D. T. (1997). Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine. Infection and Immunity, 65, 1716–1721.
   PubMed Web of Science ®Google Scholar
• Stevenson, M. & Tam, M. (1993). Differential induction of T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clinical and Experimental Immunology, 92, 77–83.
   PubMed Web of Science ®Google Scholar
• Steward, M. W., Collins, M. J., Stanley, C. & Devey, M. E. (1981). Chronic antigen-antibody-complex glomerulonephritis in mice. British Journal of Experimental Pathology, 62, 614–622.
   PubMedGoogle Scholar
• Zavala, F., Masuda, A., Graves, P. M., Nussenzweig, V. & Nussenzweig, R. S. (1985). Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites. Journal of Immunology, 35, 2790–2793.
   Google Scholar